Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023; 46: 384-390

Journal article

Open access

Peer reviewed

Julien Bezin, Clement Mathieu, Jean-Luc Faillie and Antoine Pariente

Diabetes Care, Vol.46(5), pp.e121-e122

01/05/2023

PMID: 37185689

Files and links (2)

url

Find in HALView

url

https://doi.org/10.2337/dci23-0016View

Published (Version of record) Open

1 Record Views

Title: Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023; 46: 384-390
Creators - without role: Julien Bezin - Université de Bordeaux
Clement Mathieu - Bordeaux Population Health
Jean-Luc Faillie - Université de Montpellier, Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
Antoine Pariente - Bordeaux Population Health
Publication Details: Diabetes Care, Vol.46(5), pp.e121-e122
Grant note: Agence Nationale de Sécurité du Médicament et des Produits de Santé
Identifiers: 9939013309311
Academic Unit: Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
Language: English
Resource Type: Journal article
Local Fields: hal-04140686